← Back
Data updated: Mar 10, 2026
ARROW INTL
Oncology
ARROW INTL is a generic drug manufacturer focused on Oncology.
2021
Since
1
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LENALIDOMIDE 2026-02-02
LENALIDOMIDE 2025-11-14
LENALIDOMIDE 2025-09-16
LENALIDOMIDE 2025-05-22
LENALIDOMIDE 2025-03-03
LENALIDOMIDE 2025-01-31
LENALIDOMIDE 2024-09-11
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-05-21
- Latest
- 2023-03-24
- Applications
- 1